GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

Rhea-AI Summary

GRAIL (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference. The presentation is scheduled for Wednesday, August 13 at 8:30 a.m. ET in Boston.

Investors can access both live and replay webcasts through GRAIL's investor relations website at investors.grail.com. The webcast recording will remain available for a minimum of 30 days following the event.

News Market Reaction

+1.30%

1 alert

+1.30% News Effect

On the day this news was published, GRAL gained 1.30%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, Aug. 13 at 8:30 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-canaccord-genuity-45th-annual-growth-conference-302517743.html

SOURCE GRAIL, Inc.

FAQ

When is GRAIL (GRAL) presenting at the Canaccord Genuity Growth Conference?

GRAIL will present at the conference on Wednesday, August 13, 2025, at 8:30 a.m. ET in Boston.

How can investors access GRAIL's Canaccord conference presentation?

Investors can access both the live and replay webcasts through GRAIL's investor relations website at investors.grail.com.

How long will GRAIL's Canaccord conference presentation be available for replay?

The webcast will be archived and available for replay for at least 30 days after the event.

What is GRAIL's (GRAL) main business focus?

GRAIL is a healthcare company focused on early cancer detection with the mission of detecting cancer early when it can be cured.